| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V2698 | BAY-61-3606 | 732983-37-8 | BAY-61-3606 (BAY 61-3606, BAY 61-3606), cell-permeable imidazopyrimidine compound, is a potent and selective, oral, ATP-competitive, reversible inhibitor of Syk (Spleen tyrosine kinase) tyrosine kinase with Ki of 7.5 nM. |
|
V2676 | BAY-61-3606 dihydrochloride | 648903-57-5 | BAY-61-3606 2HCl (BAY 61-3606, BAY 61-3606 dihydrochloride), cell-permeable imidazopyrimidine compound, is a potent and selective, oral, ATP-competitive, reversible inhibitor of Syk (Spleen tyrosine kinase) tyrosine kinase with immunomodulatory effects. |
|
V2680 | PRT-060318 | 1194961-19-7 | PRT-060318 (also known as PRT318) is a novel, potent,selective inhibitor of the Syk tyrosine kinase, as an approach to HIT treatment. |
|
V2679 | PRT-060318 3HCl | 1194961-19-7 | PRT-060318 3HCl (also known as PRT318 3HCl) is a novel, potent,selective inhibitor of the Syk tyrosine kinase, as an approach to HIT treatment. |
|
V2673 | RO9021 | 1446790-62-0 | RO9021 (RO-9021) is a potent, orally bioavailavle, ATP-competative and selective inhibitor of spleen tyrosine kinase (SYK) with usefulness in autoimmune disease therapy, such as arthritis. |
|
V145484 | Syk-IN-13 | 1360905-04-9 | Syk-IN-13 is a Syk inhibitor that may be used in research on rheumatoid arthritis and/or systemic lupus erythematosus. |
|
V69779 | Syk-IN-8 | 2568963-01-7 | Syk-IN-8 (compound 19q) is a Syk inhibitor (antagonist) with antiproliferation activity against a variety of hematological tumor cells. |
|
V0651 | Tamatinib (R-406) | 841290-80-0 | Tamatinib (formerly known as R406) is a novel potent and ATP competitive Syk inhibitor with potential to treat immune disorders and inflammatory conditions. |
|
V146413 | TREM2 agonist-3 | TREM2 agonist-3 is a TREM2 agonist with a KD value of 19.0 µM. | |
|
V0655 | Entospletinib (GS9973) | 1229208-44-9 | Entospletinib (formerly known as GS-9973) is a novel, potent, orally bioavailable, and highly selective Syk inhibitor with potential anti-inflammatory and immunomodulatory activities. |
|
V0654 | Piceatannol (Astringenin; NSC-622471; trans-Piceatannol) | 10083-24-6 | Piceatannol (also known as Astringenin; NSC-622471; trans-Piceatannol), a naturally occuring stilbene, is a potent and selective Syk inhibitor and shows ~10-fold selectivity for Srk over Lyn. |
|
V0653 | Fostamatinib (R788; Tavalisse) | 901119-35-5 | Fostamatinib (formerly also known as R788; trade name:Tavalisse), a prodrug of the active metabolite R406, is an orally bioactive, potent and selective Syk inhibitor with potential anti-inflammatory activity. |
|
V0657 | Fostamatinib Disodium (R788; Tavalisse) | 1025687-58-4 | Fostamatinib disodium (also known as R-788; R-935788; brand name:Tavalisse) is the prodrug form of the active metabolite R406. |